Cell implantation therapies for Parkinson's disease using neural stem, transgenic or xenogeneic donor cells

Parkinsonism and Related Disorders

Volumn 7, Issue 3, 2001, Pages 205-212

  Isacson, O ^a   Costantini, L ^a   Schumacher, J M ^a,b   Cicchetti, F ^a   Chung, S ^a   Kim, K S ^a  

^a MCLEAN HOSPITAL   (United States)

^b SARASOTA MEMORIAL HOSPITAL   (United States)

Author keywords

Dopamine; Fetal cell; Parkinson's disease; Regeneration; Stem cells; Transplantation

Indexed keywords

CELL TRANSPLANTATION; CELL TYPE; CONFERENCE PAPER; DISEASE COURSE; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; FETUS CELL; HUMAN; NERVE CELL DEGENERATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; STEM CELL; SYNAPTIC TRANSMISSION; TRANSGENE; XENOGRAFT;

EID: 0035042254     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1353-8020(00)00059-6     Document Type: Conference Paper

References (71)

1. Transplantation of fetal substantia nigra and adrenal medulla to the caudate putamen in two patients with Parkinson's disease
2. Transplantation of adrenal medullary tissue to striatum in parkinsonism
3. Bilateral fetal mesencephalic grafting in two patients with severe parkinsonism induced by MPTP
4. Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient
5. Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease
6. Survival of implanted fetal dopamine cells and neurologic improvement 12 and 46 months after transplantation for Parkinson's disease
7. Functional fetal nigral grafts in a patient with Parkinson's disease: chemoanatomic, ultrastructural, and metabolic studies
8. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease
9. A primate model of Huntington's disease: cross-species implantation of striatal precursor cells to the excitotoxically lesioned baboon caudate-putamen
10. Intrastriatal grafting of cross-species fetal striatal cells reduces abnormal movements in a primate model of Huntington's disease
11. Prevention of mouse-rat brain xenograft rejection by a combination therapy of cyclosporin A, prednisolone and azathioprine
12. Xenotransplantation of porcine fetal ventral mesencephalon in a rat model of Parkinson's disease: functional recovery and graft morphology
13. Transplanted xenogeneic neural cells in neurodegenerative disease models exhibit remarkable axonal target specificity and distinct growth patterns of glial and axonal fibres
14. Neural xenotransplantation: reconstruction of neuronal circuitry across species barriers
15. Benefits and risks of hosting animal cells in the human brain
16. Transplantation of embyonic porcine mesencephalic tissue in patients with PD
17. Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease
18. Neural transplantation studies reveal the brain's capacity for continuous reconstruction
19. Functional effects of mesencephaic dopamine neurons and adrenal chromaffin cells grafted to the rodent striatum
20. Functional studies of neural grafts in parkinsonian primates
21. Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test
22. Graft-derived recovery from 6-OHDA lesions: specificity of ventral mesencephalic graft tissue
23. In vivo PET imaging in rat of dopamine terminals reveals functional neural transplants
24. Reinnervation of the denervated striatum by substantia nigra transplants: functional consequences as revealed by pharmacological and sensorimotor testing
25. Behavioral and anatomical correlates of immunologically induced rejection of nigral xenografts
26. Mechanisms of action of intracerebral neural implants: Studies on nigral and striatal grafts to the lesioned striatum
27. Freeman
28. BDNF enhances the functional reinnervation of the striatum by grafted fetal dopamine neurons
29. Lazaroids improve the survival of grafted embryonic dopamine neurons
30. Co-transplantation of fetal lateral ganglionic eminence and ventral mesencephalon can augment function and development of intrastriatal transplants
31. Intrastriatal grafting of dopamine-containing neuronal cell suspensions: effects of mixing with target or non-target cells
32. A microtransplantation approach for cell suspension grafting in the rat Parkinson model: a detailed account of the methodology
33. Better cells for brain repair
34. Influence of BDNF on the expression of the dopaminergic phenotype of tissue used for brain transplants
35. Mitogenic effect of basic fibroblast growth factor on embryonic ventral mesencephalic dopaminergic neurone precursors
36. Effects of glial cell line-derived neurotrophic factor on developing and mature ventral mesencephalic grafts in oculo
37. GDNF triggers fiber outgrowth of fetal ventral mesencephalic grafts from nigra to striatum in 6-OHDA-lesioned rats
38. Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts
39. Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats
40. Correlation of functional recovery after 6-OHDA lesion with survival of grafted fetal neurons and release of dopamine in the striatum of the rat
41. Long distance directed axonal growth from human dopaminergic mesencephalic neuroblasts implanted along the nigrostriatal pathway in 6-hydroxydopamine lesioned adult rats
42. Intracerebral grafting of neuronal cell suspensions. IV Behavioral recovery in rats with unilateral 6-OHDA lesions in different brain sites
43. Differential dissection of the rat E16 ventral mesencephalon and survival and reinnervation of the 6-OHDA-lesioned striatum by a subset of aldehyde dehydrogenase-positive TH neurons
44. Dopamine and cholecystokinin immunoreactive neurons in mesencephalic grafts reinnervating the neostriatum: evidence for selective growth regulation
45. Substantia nigra transplants into denervated striatum of the rat: ultrastructure of graft and host interconnections
46. Host afferents into intrastriatal transplants of fetal ventral mesencephalon
47. Treatment of severe Parkinson's disease by intraventricular injection of dopamine
48. Dopamine-mediated gene regulation in the striatum
49. Intrastriatal mesencephalic grafts affect neuronal activity in basal ganglia nuclei and their target structures in a rat model of Parkinson's disease
50. Metabolic energy capacity of dopaminergic grafts and the implanted striatum in parkinsonian nonhuman primates as visualized with cytochrome oxidase histochemistry
51. Autoregulation of dopamine release and metabolism by intrastriatal nigral grafts as revealed by intracerebral dialysis
52. Fetal dopamine neuron transplants prevent behavioral supersensitivity induced by repeated administration of L-Dopa in the rat
53. Long-term survival of human central nervous system progenitor cells transplanted into a rat model of Parkinson's disease
54. Survival and differentiation of rat and human epidermal growth factor-responsive precursor cells following grafting into the lesioned adult central nervous system
55. Long-term survival of transplanted basal forebrain cells following in vitro propagation with fibroblast growth factor-2
56. Immortaized neural progenitor cells for CNS gene transfer and repair
57. Region-specific differentiation of the hippocampal stem cell line HiB5 upon implantation into the developing mammalian brain
58. Establishment and characterization of multipotent neural cell lines using retrovirus vector-mediated oncogene transfer
59. Multipotent neural cell lines can engraft and participate in development of mouse cerebellum
60. A short term analysis of the behavior of conditionally immortalized neuronal progenitors and primary neuroepithelial cells implanted in the fetal rat brain
61. Survival, integration and differentiation of neural stem cell lines after transplantation to the adult rat striatum
62. Transplanted human neurons derived from a teratocarcinoma cell line (NTera-2) mature, integrate, and survive for over 1 year in the nude mouse brain
63. Murine embryonal carcinoma-derived neurons survive and mature following transplantation into adult rat striatum
64. Catecholaminergic neurons result from the intracerebral implantation of embryonal carcinoma cells
65. Proliferation, cell death, and neuronal differentiation in transplanted human embryonal carcinoma (NTera2) cells depend on the graft site in nude and severe combined immunodeficient mice
66. Specific axon guidance factors persist in the mature rat brain: evidence from fetal neuronal xenografts
67. Vertebrate embryonic cells will become nerve cells unless told otherwise
68. Neural differentiation of Xenopus laevis ectoderm takes place after disaggregation and delayed reaggregation without inducer
69. Induction of epidemis and inhibition of neural fate by Bmp-4
70. Bone morphogenic proteins: multifunctional regulators of vertebrate development
71. Defects in enteric innervation and kidney development in mice lacking GDNF